Comment Period on Follow-on Protein Products Extended
02/16/2005
Federal Register Notice: FDA is reopening until 3/16, the comment period for the notice that appeared in the 8/16/04 Federal Register. In the notice, FDA announced a public workshop on scientific and technical considerations related to the development of follow-on protein pharmaceutical products and plans to develop draft guidance and requested comments related to developing and approving follow-on protein pharmaceutical products. To view this notice, click here.
